SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 208 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,403,000 | +197.9% | 148,502 | +182.7% | 0.09% | +172.7% |
| Q2 2020 | $471,000 | +375.8% | 52,527 | +405.5% | 0.03% | +371.4% |
| Q1 2019 | $99,000 | -88.4% | 10,392 | -86.1% | 0.01% | -87.0% |
| Q4 2018 | $857,000 | +62.0% | 74,673 | +168.0% | 0.05% | +45.9% |
| Q1 2018 | $529,000 | +25.1% | 27,862 | +8.0% | 0.04% | -19.6% |
| Q4 2017 | $423,000 | -41.7% | 25,790 | -68.7% | 0.05% | -76.9% |
| Q2 2017 | $726,000 | +881.1% | 82,478 | +417.0% | 0.20% | +1070.6% |
| Q3 2016 | $74,000 | -66.7% | 15,952 | -56.5% | 0.02% | -34.6% |
| Q1 2016 | $222,000 | -60.8% | 36,687 | +1.6% | 0.03% | -55.2% |
| Q1 2015 | $566,000 | -55.7% | 36,100 | -57.0% | 0.06% | -74.3% |
| Q4 2014 | $1,277,000 | – | 83,958 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |